182 related articles for article (PubMed ID: 10389988)
1. Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells.
Takenaga K
Br J Cancer; 1999 Apr; 80(1-2):127-32. PubMed ID: 10389988
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines.
Nakamura N; Takenaga K
Clin Exp Metastasis; 1998 Jul; 16(5):471-9. PubMed ID: 10091942
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest.
Andersen K; Smith-Sørensen B; Pedersen KB; Hovig E; Myklebost O; Fodstad Ø; Maelandsmo GM
Br J Cancer; 2003 Jun; 88(12):1995-2001. PubMed ID: 12799648
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
5. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
6. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
7. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases.
Komatsu K; Murata K; Kameyama M; Ayaki M; Mukai M; Ishiguro S; Miyoshi J; Tatsuta M; Inoue M; Nakamura H
Oncology; 2002; 63(2):192-200. PubMed ID: 12239456
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma-induced suppression of S100A4 transcription is mediated by the class II transactivator.
Boye K; Andersen K; Tveito S; Øyjord T; Maelandsmo GM
Tumour Biol; 2007; 28(1):27-35. PubMed ID: 17143014
[TBL] [Abstract][Full Text] [Related]
9. S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells.
Gao XN; Tang SQ; Zhang XF
J Pediatr Surg; 2005 Apr; 40(4):648-52. PubMed ID: 15852272
[TBL] [Abstract][Full Text] [Related]
10. The role of S100A4 gene encoding an S100-related calcium-binding protein in human bile duct adenocarcinoma cell lines: correlation of S100A4 expression and invasive growth in Matrigel Matrix.
Katayama N; Murao S; Ajiki T; Kitazawa S; Onoyama H; Kuroda Y; Maeda S
Int J Mol Med; 2000 Nov; 6(5):539-42. PubMed ID: 11029520
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4.
Pedersen KB; Andersen K; Fodstad Ø; Maelandsmo GM
BMC Cancer; 2004 Aug; 4():52. PubMed ID: 15318945
[TBL] [Abstract][Full Text] [Related]
12. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon.
Takahashi H; Okai Y; Paxton RJ; Hefta LJ; Shively JE
Cancer Res; 1993 Apr; 53(7):1612-9. PubMed ID: 8453631
[TBL] [Abstract][Full Text] [Related]
14. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
[TBL] [Abstract][Full Text] [Related]
15. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
[TBL] [Abstract][Full Text] [Related]
16. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
17. Establishment of new interferon-gamma-resistant mutant cells with dominant phenotypes.
Ohta T; Ando O; Kurimoto M
J Interferon Cytokine Res; 1995 Feb; 15(2):153-60. PubMed ID: 8590319
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of metastatic potential by gamma-interferon.
Kelly SA; Gschmeissner S; East N; Balkwill FR
Cancer Res; 1991 Aug; 51(15):4020-7. PubMed ID: 1906780
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
